Positive intraoperative peritoneal lavage cytology is a negative prognostic factor in pancreatic ductal adenocarcinoma: a retrospective single-center study

被引:23
|
作者
Hirabayashi, Kenichi [1 ]
Imoto, Akiko [1 ]
Yamada, Misuzu [2 ]
Hadano, Atsuko [3 ]
Kato, Nobuaki [4 ]
Miyajima, Youko [4 ]
Ito, Hitoshi [4 ]
Kawaguchi, Yoshiaki [3 ]
Nakagohri, Toshio [2 ]
Mine, Tetsuya [3 ]
Nakamura, Naoya [1 ]
机构
[1] Tokai Univ, Sch Med, Dept Pathol, Isehara, Kanagawa 2591193, Japan
[2] Tokai Univ, Sch Med, Dept Surg, Isehara, Kanagawa 2591193, Japan
[3] Tokai Univ, Sch Med, Dept Gastroenterol & Hepatol, Isehara, Kanagawa 2591193, Japan
[4] Tokai Univ Hosp, Div Diagnost Pathol, Isehara, Kanagawa, Japan
来源
FRONTIERS IN ONCOLOGY | 2015年 / 5卷
关键词
cytology; peritoneal lavage; ascites; pancreatic cancer; adenocarcinoma; survival analysis; CANCER; SURVIVAL; WASHINGS;
D O I
10.3389/fonc.2015.00182
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The aim of this study is to evaluate the prognostic significance of intraoperative peritoneal lavage cytology (PLC) in pancreatic invasive ductal adenocarcinoma. Methods: Intraoperative PLC was evaluated in 162 patients with resectable pancreatic invasive ductal adenocarcinoma. The results were analyzed for correlations with clinicopathological parameters and/or prognoses. Results: In the 162 cases of resectable pancreatic ductal adenocarcinoma, 18 (11%), 141 (87%), and 3 (2%) were positive, negative, and equivocal for intraoperative PLC, respectively. Intraoperative PLC positivity was associated with older patients (over 65 years), large tumor size (over 35 mm), tumor location in the body/tail of the pancreas, and distant metastasis. Univariate analysis showed that larger tumor sizes (>= 35 mm, P = 0.001), lymph node metastases (P = 0.005), distant metastasis (P = 0.004), advanced stage (stage IIB or III, P = 0.006), advanced tumor histological grade (G3, P < 0.001), or positive intraoperative PLC (P = 0.002) are associated with a shorter survival. Multivariate analysis revealed that larger tumor sizes (>= 35 mm, P = 0.026), lymph node metastasis (P = 0.021), advanced tumor histological grade (G3, P <0.001), and positive intraoperative PLC (P = 0.002) were independent prognostic factors. Conclusion: Intraoperative PLC is an independent prognostic factor for resectable pancreatic invasive ductal adenocarcinoma.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Preoperative risk factors for positivity of peritoneal lavage cytology in patients with pancreatic ductal adenocarcinoma in the era of neoadjuvant therapy
    Otsuka, Hiroyuki
    Uemura, Kenichiro
    Kondo, Naru
    Sumiyoshi, Tatsuaki
    Okada, Kenjiro
    Seo, Shingo
    Murakami, Yoshiaki
    Takahashi, Shinya
    PANCREATOLOGY, 2022, 22 (05) : 583 - 589
  • [22] Lymph Node Characteristics and Short-Term Outcomes for Resectable Pancreatic Ductal Adenocarcinoma in Vietnam: A Retrospective Single-Center Study
    Lan Thi Nguyen
    Dang Hai Do
    Hung Van Nguyen
    Khiem Thanh Nguyen
    Chinh Duc Nguyen
    Indian Journal of Surgery, 2022, 84 : 458 - 463
  • [23] Lymph Node Characteristics and Short-Term Outcomes for Resectable Pancreatic Ductal Adenocarcinoma in Vietnam: A Retrospective Single-Center Study
    Lan Thi Nguyen
    Dang Hai Do
    Hung Van Nguyen
    Khiem Thanh Nguyen
    Chinh Duc Nguyen
    INDIAN JOURNAL OF SURGERY, 2022, 84 (SUPPL 2) : 458 - 463
  • [24] Cytoglobin as a Prognostic Factor for Pancreatic Ductal Adenocarcinoma A Retrospective Analysis of 75 Patients
    Kono, Hiroshi
    Hosomura, Naohiro
    Amemiya, Hidetake
    Kawaida, Hiromichi
    Furuya, Shinji
    Akaike, Hidenori
    Kawaguchi, Yoshihiko
    Sudo, Makoto
    Ichikawa, Daisuke
    PANCREAS, 2021, 50 (07) : 994 - 999
  • [25] Recurrence and survival prediction models for receiving preoperative chemotherapy pancreatic ductal adenocarcinoma: a single-center retrospective research
    Zhang, Yixin
    Han, Xin
    Sun, Zhongquan
    You, Wanlu
    Cao, Haoze
    Wu, Xiaochang
    Wang, Weilin
    Ding, Yuan
    JOURNAL OF PANCREATOLOGY, 2025, 8 (01) : 41 - 47
  • [26] Increased expression of calponin 2 is a positive prognostic factor in pancreatic ductal adenocarcinoma
    Qiu, Zhaoyan
    Chu, Yi
    Xu, Bing
    Wang, Qian
    Jiang, Mingzuo
    Li, Xiaowei
    Wang, Gang
    Yu, Pengfei
    Liu, Guoxiao
    Wang, Hua
    Kang, Huijie
    Liu, Jiayu
    Zhang, Yu
    Jin, Jian-Ping
    Wu, Kaichun
    Liang, Jie
    ONCOTARGET, 2017, 8 (34) : 56428 - 56442
  • [27] Prognostic factors for recurrence in resected pancreatic adenocarcinoma: A single-center experience
    Di Marco, M.
    Macchini, M.
    Ricci, C.
    Taffurelli, G.
    D'Ambra, M.
    Vecchiarelli, S.
    Pallotti, M. C.
    Pezzilli, R.
    Martoni, A. A.
    Casadei, R.
    Biasco, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] A single-center retrospective analysis of allergies and survival outcomes in pancreatic adenocarcinoma
    Li, Peter Chi-Win
    Saldia, Amethyst
    Olson, Sara
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Nab-paclitaxel plus S1 with or without sintilimab in metastatic pancreatic ductal adenocarcinoma: A single-center, retrospective study
    Liu, Q.
    Liu, R.
    Zhao, Z.
    Wang, F.
    Wang, Y.
    Li, X.
    Ma, T.
    ANNALS OF ONCOLOGY, 2020, 31 : S943 - S943
  • [30] Oncological role of surgical resection in patients with pancreatic ductal adenocarcinoma with liver-only synchronous metastases in a single-center retrospective study
    Satoi, Sohei
    Yamamoto, Tomohisa
    Hashimoto, Daisuke
    Yamaki, So
    Matsui, Yuki
    Ikeura, Tsukasa
    Boku, Shogen
    Shibata, Nobuhiro
    Tsybulskyi, Denys
    Sekimoto, Mitsugu
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (06) : 2587 - 2599